Precision Biosciences (DTIL) Return on Equity (2019 - 2025)
Historic Return on Equity for Precision Biosciences (DTIL) over the last 7 years, with Q3 2025 value amounting to 3.39%.
- Precision Biosciences' Return on Equity fell 33900.0% to 3.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.39%, marking a year-over-year decrease of 33900.0%. This contributed to the annual value of 0.47% for FY2023, which is 400.0% up from last year.
- Latest data reveals that Precision Biosciences reported Return on Equity of 3.39% as of Q3 2025, which was down 33900.0% from 2.06% recorded in Q2 2025.
- Precision Biosciences' 5-year Return on Equity high stood at 0.42% for Q2 2024, and its period low was 3.39% during Q3 2025.
- In the last 5 years, Precision Biosciences' Return on Equity had a median value of 0.78% in 2023 and averaged 0.91%.
- Its Return on Equity has fluctuated over the past 5 years, first surged by 16100bps in 2021, then tumbled by -33900bps in 2025.
- Quarter analysis of 5 years shows Precision Biosciences' Return on Equity stood at 0.41% in 2021, then plummeted by -151bps to 1.02% in 2022, then grew by 23bps to 0.78% in 2023, then soared by 55bps to 0.35% in 2024, then crashed by -871bps to 3.39% in 2025.
- Its Return on Equity stands at 3.39% for Q3 2025, versus 2.06% for Q2 2025 and 0.74% for Q1 2025.